|
Getting your Trinity Audio player ready...
|
When the MHRA’s Dame June Raine said her organisation was shifting from being a watchdog to being an enabler, she meant it.
Dr. June Raine was appointed chief executive of the UK Medicines and Healthcare products Regulatory Agency (“MHRA”) in August 2019. She has been integral to the agency’s work, particularly during the covid-19 pandemic. In 2022, she was awarded a Dame Commander of the Order of the British Empire (“DBE”) in recognition of her service to the public, more specifically for “services to healthcare and the covid-19 response.” Earlier this year, it was announced she would step down as chief executive in the autumn of 2024, after five years in the role
Let’s not lose touch…Your Government and Big Tech are actively trying to censor the information reported by The Exposé to serve their own needs. Subscribe now to make sure you receive the latest uncensored news in your inbox…
Since 2020, the MHRA has developed a habit of providing assistance to well-connected US drug developers with friends in high places such as Dr. Robert Kadlec, the mastermind behind the US bio-defence project responsible for the covid-19 debacle. This assistance has taken the form of issuing questionable but critical pharmaceutical authorisations.
On 4 November 2021, following another of its ‘rigorous’ reviews, the MHRA became the first regulator in the world to authorise the oral antiviral molnupiravir, a drug in development for treating covid-19, which has a controversial history as detailed in a whistle-blower complaint filed in April 2020.
MHRA’s authorisation was granted after testing on only 775 people, despite concerns about the drug’s potential to cause birth defects. The MHRA declared the drug “safe and effective” without providing sufficient evidence to support this claim.
The MHRA issued a conditional marketing authorisation for molnupiravir, marketed in Great Britain by MSD (Merck) under the brand name Lagevrio. In Northern Ireland, where European Union law remains in effect, the MHRA issued a Regulation 174 authorisation for temporary supply, as a conditional marketing authorisation would have required approval from the European Medicines Agency.
Contrasting with the MHRA, the US Food and Drug Administration (“FDA”) delayed approving molnupiravir due to concerns shared by some reviewers about its potential to cause birth defects. The FDA ultimately approved the drug on 23 December 2021, seven weeks after the MHRA’s authorisation – raising suspicions that some members of the FDA’s equivalent of the UK Commission on Human Medicines reviewing Merck’s application may have been swayed by the prior MHRA authorisation, which could have influenced their decision.
The MHRA’s authorisation of molnupiravir before adequate testing raises concerns about its priorities and standards. The drug’s conditional marketing authorisation remains in place, despite lack of efficacy being an insufficient reason for the MHRA to withdraw the authorisation. This suggests that commercial interests may have played a role in the decision-making process.
The MHRA’s review process and decision-making surrounding molnupiravir’s authorisation remain opaque. The agency’s assurances about the drug’s safety and efficacy lack transparency, and the public is left to question the true motivations behind the authorisation.
The above is a summary of the two-part series ‘Yet another MHRA drug scandal’ published by the Conservative Woman. You can read the full articles HERE and HERE.
The Expose Urgently Needs Your Help…
Can you please help to keep the lights on with The Expose’s honest, reliable, powerful and truthful journalism?
Your Government & Big Tech organisations
try to silence & shut down The Expose.
So we need your help to ensure
we can continue to bring you the
facts the mainstream refuses to.
The government does not fund us
to publish lies and propaganda on their
behalf like the Mainstream Media.
Instead, we rely solely on your support. So
please support us in our efforts to bring
you honest, reliable, investigative journalism
today. It’s secure, quick and easy.
Please choose your preferred method below to show your support.
Categories: Breaking News
https://beforeitsnews.com/agenda-21/2024/07/israels-propaganda-bots-juan-o-savin-judy-byington-checkur6-young-virus-poison-vaccine-hearts-part-57-15th-july-2024-4997.html
If you wondered where the sports players had gone.
As with EVERY “questionable decision” from these in NO respect “independent” regulatory bodies, what we observe is not merely naked profiteering & commercial self interest via wholesale complicity & collusion with the biopharmaceutical industrial complex cartels, but, as so unambiguously & conspicuously noted with the D.o.D.’s C19 “military countermeasures/prototype” jabs, yet MORE wilful initiatives to sicken, maim, deform & destroy us from the molochite priesthood of these psychopathic purveyors of pharmakeia. The ENTIRE Rockefeller Foundation petroleum based western allopathic pharmacological model is a consciously, purposefully flawed mechanism. They will knowingly treat & prescribe with pharmaceutical interventions they are well aware are potentially going to create ghastly, irreversible side-effects, sooner or later, often very much WORSE than the symptomatology of the original complaint!! There WAS NO case of the M.H.R.A.’s decision unduly influencing that of the F.D.A. (so quickly thereafter), despite the seeming independence of each, & geographical distance between them, and separate national identities, as with the “separate” status of the pharma-cartels, I believe there is a singular entity behind, & directing them ALL, a sinister, insidious cabal & international, organized criminal conspiracy of satanic psychopaths pushing their Club of Rome/U.N. Agenda 21-2030/ Bilderberg group “Silent Weapons For Quiet Wars”/Georgia guidestones/ pLan-demic global democidal depopulation agenda, & that details like the brief delay between the single decision of each was an artifice of purely theatrical affectation, in an effort to “stagger” the decision with a delay in order to manufacture the false impression of their being separate bodies, as with nearly ALL the governments of the world immediately ditching any pretence of being independent, autonomous, sovereign entities & IMMEDIATELY all conforming to the covert, secretly pre-agreed upon SINGLE set of policies, mandates, “recommendations”, legislation & protocols- ALL in service to the advancement of the installation of their zio-globalist, eco-communitarian, great reset, risen beast-system & technological tyranny of their transhumanist New World Order. In closing, with regards to the psychopathic criminal conspiracy known as the M.H.R.A., I would strongly encourage people to refer to & familiarize themselves with UK Column’s investigation into the persecution of David Noakes & Lynn Thyer of ImmunoBiotech, whose GcMAF cancer treatment had cured up to 80% of the patients they treated, including many with stage-4 “terminal” cancer, whom the N.H.S. had sent home to die, & of how the M.H.R.A. has had Mr. Noakes dragged into court in the U.K., found guilty, demanded the MAXIMUM sentence of imprisonment, & THEN urged many of the nations of the E.U. to file “cut & paste” criminal charges against both (Lynn Thyer having ONLY been his personal assistant!!), which HAS been done, & ALL on the basis of entirely contrived charges of “off label use/promotion”, & trumped up “financial irregularities”, & ALL because he had been CURING supposedly “terminal” cancers, & threatening the existence of the corrupt “cure a patient, LOSE a CUSTOMER” criminal, immoral, & inhumane suppression of successful cancer treatments, with NO vicious side-effects, as chemotherapy et al produce without fail. Damn the M.H.R.A. & June Raine to the very depths of Hell.
Hi Greg,
Well said, could not have put it better.
Sad thing about David Noakes and Lyne Thyer, who ran a business.
If customers who were dying had no money, they were treated for free.
No wonder the medical gang went after them.
[…] https://expose-news.com/2024/07/16/why-did-the-mhra-approve-the-controversial-drug-molnupiravir/ […]
[…] Why did the MHRA approve the controversial drug molnupiravir? …The MHRA’s authorisation of molnupiravir before adequate testing raises concerns about its priorities and standards. The drug’s conditional marketing authorisation remains in place, despite lack of efficacy being an insufficient reason for the MHRA to withdraw the authorisation. This suggests that commercial interests may have played a role in the decision-making process. […]
[…] Read More […]